Published in TB and Outbreaks Week, January 9th, 2001
The researchers monitored 34 pulmonary tuberculosis patients for changes in cytokine as well as T helper cell status during the nine-month study. Patients were evaluated prior to study initiation and then every three months after they began anti-tuberculosis therapy.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week